| 000 | 02667nam a2200505 i 4500 | ||
|---|---|---|---|
| 999 |
_c293009 _d293009 |
||
| 001 | on1151883907 | ||
| 003 | OCoLC | ||
| 005 | 20200512084940.0 | ||
| 007 | he bmb024bbca | ||
| 008 | 200424s2018 dcua bb f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a1043-B (MF) | ||
| 086 | 0 | _aY 4.L 11/4:S.HRG.114-805 | |
| 099 | _aY 4.L 11/4:S.HRG.114-805 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bSenate. _bCommittee on Health, Education, Labor, and Pensions. _bSubcommittee on Children and Families, |
|
| 245 | 1 | 0 |
_aEpiPen price increases : _bhow regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY). |
| 246 | 3 | 0 | _aHow regulatory barriers inhibit pharmaceutical competition |
| 264 | 1 |
_aWashington : _bU.S. Government Publishing Office, _c2018. |
|
| 300 |
_aiii, 43 pages : _billustrations ; _c24 cm. |
||
| 336 | _btxt | ||
| 337 |
_bh _2rdamedia |
||
| 338 |
_bhe _2rdacarrier |
||
| 490 | 1 |
_aS. hrg. ; _v114-805 |
|
| 500 | _aShipping list no.: 2019-0162-M. | ||
| 500 | _aGPO Cataloging Record Distribution Program (CRDP). | ||
| 504 | _aIncludes bibliographical references. | ||
| 533 |
_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2018] _e1 microfiche : negative. |
||
| 776 | 0 | 8 |
_iPrint version: _aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families. _tEpiPen price increases _w(DLC) 2018439951 _w(OCoLC)1078409593 |
| 776 | 0 | 8 |
_iOnline version: _aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families. _tEpiPen price increases _w(OCoLC)1078951640 |
| 810 | 1 |
_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v114-805. |
|
| 050 | 4 |
_aKF26 _b.L2733 2016 |
|
| 650 | 0 |
_aPrescription pricing _zUnited States. |
|
| 650 | 0 |
_aDrugs _xLaw and legislation _zUnited States. |
|
| 650 | 0 |
_aPharmaceutical industry _zUnited States. |
|
| 650 | 0 |
_aCompetition _zUnited States. |
|
| 650 | 0 |
_aDrug delivery devices _xPrices _zUnited States. |
|
| 650 | 7 |
_aCompetition. _2fast |
|
| 650 | 7 |
_aDrugs _xLaw and legislation. _2fast |
|
| 650 | 7 |
_aPharmaceutical industry. _2fast |
|
| 650 | 7 |
_aPrescription pricing. _2fast |
|
| 651 | 7 |
_aUnited States. _2fast |
|
| 942 |
_2sudocs _c8 |
||